Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Ferring launches work...

    Ferring launches work on facility in Hyderabad's Genome Valley

    Written by Ruby Khatun Khatun Published On 2018-07-03T10:00:18+05:30  |  Updated On 3 July 2018 10:00 AM IST
    Ferring launches work on facility in Hyderabads Genome Valley

    Hyderabad: Ferring Pharmaceuticals, a pharma major from Europe, laid the foundation stone for their state-of-the-art R&D laboratory and manufacturing facility here.


    The event was attended by Telangana Industries Minister KT Rama Rao and several other dignitaries, a state government release said.




    Ferring Pharmaceuticals is a Switzerland-based Euro 2 billion research-driven specialty biopharmaceutical group and a leader in reproductive medicine and women's health. It has a strong presence in specialty areas within gastroenterology and urology, it said.


    Ferring established its Indian subsidiary in 1997 and has thus far established a manufacturing facility, an R&D centre and commercial operations in Maharashtra, it said.


    "The new facility will also add to group's global R&D capabilities and will cater to building a pool of novel research for emerging healthcare challenges around the world.


    Ferring plans to complete the project in three phases with a total proposed investment of USD 250 million, with an estimated INR 235 crore into the first phase itself," the release said.


    Welcoming Ferring to Genome Valley, a life sciences cluster here, Rao said the government is "delighted to have Ferring Pharma join the impressive list of companies who are present in this cluster".

    FerringFerring PharmaceuticalsgastroenterologyGenome ValleyHyderabadKT Rama Raolaunchesmanufacturing facilityR&D laboratoryreproductive medicineresearch and developmentTelangana Industries Ministerurologywork on facility
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok